Related Experiment Videos
Prospective isolation of multipotent pancreatic progenitors using flow-cytometric cell sorting
Atsushi Suzuki1, Hiromitsu Nakauchi, Hideki Taniguchi
1Gene Expression Laboratories, The Salk Institute for Biological Studies, La Jolla, California, USA.
Diabetes
|July 28, 2004
Summary
Researchers identified a novel marker for pancreatic stem cells (PSCs). These c-Met-expressing cells can differentiate into various pancreatic cell types, offering potential for diabetes regenerative therapies.
Area of Science:
- * Stem cell biology
- * Developmental biology
- * Regenerative medicine
Background:
- * The existence of pancreatic stem cells (PSCs) remains unconfirmed, hindering research into pancreatic development and regeneration.
- * Identifying specific markers is crucial for isolating and characterizing these potential PSCs.
Purpose of the Study:
- * To identify phenotypic markers for prospective isolation and characterization of pancreatic stem cells.
- * To investigate the role of c-Met/HGF signaling in pancreatic stem/progenitor cell function.
Main Methods:
- * Combined flow cytometry and clonal analysis in developing and adult mouse pancreas.
- * In vitro clonal colony formation and differentiation assays.
- * In vivo cell transplantation and differentiation analysis.
Main Results:
- * Identified a pancreatic stem/progenitor cell candidate expressing c-Met but lacking hematopoietic/vascular antigens (CD45, TER119, c-Kit, Flk-1).
- * These cells formed clonal colonies, differentiated into multiple pancreatic lineages (endocrine, acinar), and showed self-renewal in culture.
- * Transplanted cells differentiated into pancreatic endocrine and acinar cells in vivo.
- * Demonstrated potential for differentiation into non-pancreatic cell types (liver, stomach, intestine) in vitro.
Conclusions:
- * c-Met is a promising marker for prospective isolation of pancreatic stem cells.
- * c-Met/HGF signaling is vital for stem/progenitor cell function in both developing and adult pancreas.
- * Prospective isolation of PSCs using c-Met opens avenues for stem cell marker investigation and regenerative therapies for diabetes.